ULTRAFEM INC
424B3, 1996-09-18
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: INTERNATIONAL NURSING SERVICES INC, S-3, 1996-09-18
Next: MUNICIPAL INVT TR FD MON PYMT SER 529 DEFINED ASSET FDS, 485BPOS, 1996-09-18



<PAGE>
                        STICKER FOR ULTRAFEM PROSPECTUS
 
    On  September  13, 1996,  the Company  filed  a Registration  Statement with
respect to the offering by the Company of 3,000,000 shares (3,450,000 shares  if
the  over-allotment is exercised in full) of Common Stock. At June 30, 1996, the
Company had  an accumulated  deficit of  approximately $21  million and  working
capital  of approximately $17.9  million. During its fiscal  year ended June 30,
1996, the Company spent approximately $2.5 million in connection with the launch
of INSTEAD-TM-,  approximately $1.5  million  of which  was  spent in  the  last
quarter  of fiscal year  1996. The Company anticipates  that INSTEAD-TM- will be
available for sale by retailers  in the Pacific Northwest  in the Fall of  1996,
including the major markets of San Francisco, Seattle, and Portland. In order to
achieve  this timetable,  the Company  began shipment  of INSTEAD-TM-  in August
1996. Subsequent to the IPO in February  1996, the Company entered into a  lease
for  manufacturing  and  office space  in  Missoula, Montana  and  remodeled the
manufacturing space principally to create the controlled environment module that
secures the  manufacturing  equipment.  The  special  thermoforming  line  which
produces  INSTEAD-TM- completed high volume testing and, in June 1996, commenced
manufacturing commercial quantities of INSTEAD-TM- for the Fall 1996 launch. The
Company placed  an  order for  a  second  semi-automated line  scheduled  to  be
installed  in the Fall of 1996 and an order for a fully automated line scheduled
to be installed in the Spring of 1997. There can be no assurance, however,  that
any  of the foregoing goals or timetables can be met. Subsequent to the IPO, the
Company identified its target geography  for the initial launch of  INSTEAD-TM-,
established  a broker network,  and established certain  key trade accounts. The
initial indications from  the early stages  of the launch  reflect higher  costs
related  to trade,  distribution and  marketing spending  levels than previously
anticipated. The Company believes that this is due to the response to the launch
of INSTEAD-TM- by companies with competitive products. There can be no assurance
that the Company's competitors will not significantly increase their spending on
promotional activities as a reaction to the introduction of INSTEAD-TM-.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission